Non-Steroidal Anti-inflammatory Drugs Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What CAGR Will the Non-Steroidal Anti-inflammatory Drugs Market Achieve During 2025–2034, and What Does It Indicate?
The market for non-steroidal anti-inflammatory drugs has seen significant expansion in the previous years. The market, which currently stands at $20.68 billion in 2024, is projected to rise to $22.1 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.8%. Factors that have contributed to this growth during the historic period include a prevalence of chronic inflammatory diseases, the management of pain after surgery, sports-related injuries, over-the-counter accessibility, an older population, and an increased public awareness.
The market for non-steroidal anti-inflammatory drugs is on track for significant expansion in the coming years. Its value is forecasted to reach $28.79 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 6.8%. Factors contributing to this anticipated growth during the forecast period include the development of innovative pain management treatments, regulatory modifications, the rise in telehealth usage, worldwide wellness trends, competition from biosimilars, patient choices and the implementation of precision medicine. The primary trends for the forecast period are the dominance of the over-the-counter (OTC) market, the increase in preference for cox-2 inhibitors, generics challenging the market, and the adoption of digital health technologies.
What Factors Are Propelling the Growth of the non-steroidal anti-inflammatory drugs Market from 2025 to 2034?
The increasing occurrence of chronic pain, a discomfort that lasts for more than six months, is anticipated to drive the growth of the non-steroidal anti-inflammatory drugs market. These drugs play a crucial role in treating injuries and addressing chronic pain. As per a report published by the CDC (Centers for Disease Control and Prevention), a US government agency, in April 2022, arthritis is an often-cited cause of chronic pain, affecting millions of US citizens. Around one in four adults suffer from severe joint pain related to arthritis, representing approximately 15 million people. As such, the rising prevalence of chronic pain forms a significant growth factor for the non-steroidal anti-inflammatory drugs market.
Explore Comprehensive Insights Into The Global Non-Steroidal Anti-inflammatory Drugs Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp
Who Are the Key Firms Paving the Way for Growth in the Non-Steroidal Anti-inflammatory Drugs Market?
Major companies operating in the non-steroidal anti-inflammatory drugs market are:
• Pfizer Inc._x000D_
• Bayer AG_x000D_
• Johnson & Johnson_x000D_
• Sun Pharmaceutical Industries Ltd._x000D_
• Assertio Therapeutics Inc._x000D_
What Are the Most Influential Trends Currently Shaping the Non-Steroidal Anti-inflammatory Drugs Market?
In the realm of non-steroidal anti-inflammatory drugs, product innovation is becoming a principal trend. Key players in this market are diverting their efforts towards the development of innovative technological solutions. For example, in March 2024, Endo International plc, a pharmaceutical enterprise based in Ireland, introduced ibuprofen-famotidine 800 mg/26.6 mg tablets. These tablets amalgamate the pain-relieving and anti-inflammatory characteristics of ibuprofen with the stomach-protecting benefits of famotidine. This unique combination aims to relieve pain while reducing the likelihood of gastrointestinal complications often linked with the prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen.
Secure Your Global Non-Steroidal Anti-inflammatory Drugs Market Report Now for Fast and Efficient Delivery!
What Major Market Segments Define the Scope and Growth of the Non-Steroidal Anti-inflammatory Drugs Market?
The non-steroidal anti-inflammatory drugs market covered in this report is segmented –
1) By Route Of Administration: Oral, Topical, Other Route Of Administration
2) By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Oral: Tablets, Capsules, Liquids Or Solutions
2) By Topical: Gels, Creams, Patches
3) By Other Route Of Administration: Injectable (Intravenous And Intramuscular), Suppositories
Which Regions Are Essential for the Growth of the Non-Steroidal Anti-inflammatory Drugs Market?
North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the non-steroidal anti-inflammatory drugs market during the forecast period. The regions covered in the non-steroidal anti-inflammatory drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Definition of the Non-Steroidal Anti-inflammatory Drugs Market Impacting Future Growth?
Non-steroidal anti-inflammatory drugs are medications that reduce inflammation and lower a fever. They are used to treat headaches, sprains and strains, painful periods, colds and flu, arthritis, and other long-term pain conditions, and to reduce inflammation, relieve pain, and bring down a high temperature.
Browse Through More Similar Reports By The Business Research Company:
Acne Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report
Antiemetics And Antinauseants Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report
Branded Generics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/branded-generics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
